Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Aneurysm Clips Market, by Material
1.4.2 North America Aneurysm Clips Market, by End-use
1.4.3 North America Aneurysm Clips Market, by Indication
1.4.4 North America Aneurysm Clips Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Aneurysm Clips Market by Material
3.1 North America Titanium Aneurysm Clips Market by Country
3.2 North America Polymer Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Aneurysm Clips Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Ambulatory Surgical Centers Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Aneurysm Clips Market by Indication
5.1 North America Stroke Market by Country
5.2 North America Cerebral Artery Stenosis Market by Country
5.3 North America Cerebral Aneurysm Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Aneurysm Clips Market by Country
6.1 US Aneurysm Clips Market
6.1.1 US Aneurysm Clips Market by Material
6.1.2 US Aneurysm Clips Market by End-use
6.1.3 US Aneurysm Clips Market by Indication
6.2 Canada Aneurysm Clips Market
6.2.1 Canada Aneurysm Clips Market by Material
6.2.2 Canada Aneurysm Clips Market by End-use
6.2.3 Canada Aneurysm Clips Market by Indication
6.3 Mexico Aneurysm Clips Market
6.3.1 Mexico Aneurysm Clips Market by Material
6.3.2 Mexico Aneurysm Clips Market by End-use
6.3.3 Mexico Aneurysm Clips Market by Indication
6.4 Rest of North America Aneurysm Clips Market
6.4.1 Rest of North America Aneurysm Clips Market by Material
6.4.2 Rest of North America Aneurysm Clips Market by End-use
6.4.3 Rest of North America Aneurysm Clips Market by Indication
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Integra LifeSciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 B. Braun Melsungen AG (Aesculap, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 KLS Martin Group
7.8.1 Company Overview
7.9 Adeor Medical AG
7.9.1 Company Overview
7.10. Evonos GmbH & Co. KG
7.10.1 Company Overview
Unique Offerings 